Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality (Q42277755)

19 October 2017

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality (English)

1 reference

19 October 2017

Pseudomonas aeruginosa

0 references

respirator

1 reference

inferred from title

multiple drug resistance

1 reference

C Peña

1

1 reference

19 October 2017

S Gómez-Zorrilla

2

1 reference

19 October 2017

I Oriol

3

1 reference

19 October 2017

F Tubau

4

1 reference

19 October 2017

M A Dominguez

5

1 reference

19 October 2017

M Pujol

6

1 reference

19 October 2017

J Ariza

7

1 reference

19 October 2017

24 January 2013

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

19 October 2017

1 reference

19 October 2017

32

1 reference

19 October 2017

3

1 reference

19 October 2017

413-420

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-012-1758-8

19 October 2017

0 references

cites work

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Should antibiotic combinations be used to treat ventilator-associated pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

The effect of late-onset ventilator-associated pneumonia in determining patient mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Appropriateness and delay to initiate therapy in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1758-8

Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy

21 January 2018

1 reference

12 December 2020

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes

1 reference

12 December 2020

Outcome of postoperative pneumonia in the Eole study

1 reference

12 December 2020

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

12 December 2020

Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections

1 reference

12 December 2020

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group

1 reference

12 December 2020

A simplified acute physiology score for ICU patients

1 reference

12 December 2020

10.1007/S10096-012-1758-8

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference